Praxis Precision Medicines (PRAX) Stock Chart & Stock Price History $46.68 -0.58 (-1.23%) As of 07/7/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Praxis Precision Medicines Stock Price Performance The Praxis Precision Medicines (PRAX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 10.15%, with a year-to-date return of -39.35%. In the past month, the stock has increased 4.76%, reflecting recent market activity. As of the latest close, Praxis Precision Medicines traded at $46.68 with a market cap of $950.87 million and volume of 230,231 shares. Receive PRAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Praxis Precision Medicines and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-1.26%1 Month Performance+4.76%3 Month Performance+63.22%Year-To-Date Performance-39.35%1 Year Performance+10.15% PRAX Stock Chart for Tuesday, July, 8, 2025 PRAX Chart by TradingView Praxis Precision Medicines Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/07/2025$47.28$46.68-1.26%$47.72$46.00230,231 shs$950.87 million07/04/2025$47.28$47.28$48.00$45.65242,860 shs$962.99 million07/03/2025$46.32$47.28+2.06%$48.00$45.65242,860 shs$962.94 million07/02/2025$43.17$46.32+7.30%$46.60$42.69243,685 shs$943.54 million07/01/2025$42.05$43.17+2.66%$43.88$40.93202,892 shs$879.37 million06/30/2025$43.00$42.05-2.21%$43.24$42.05341,828 shs$856.56 million06/27/2025$44.04$43.00-2.36%$44.40$42.44607,522 shs$875.91 million06/26/2025$43.33$44.04+1.64%$44.38$41.75183,030 shs$897.10 million06/25/2025$43.96$43.33-1.43%$44.10$42.49149,589 shs$882.63 million06/24/2025$41.63$43.96+5.60%$44.02$41.41217,701 shs$895.42 million Get the Latest News and Ratings for PRAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Praxis Precision Medicines and its competitors with MarketBeat's FREE daily newsletter. 06/23/2025$42.34$41.63-1.68%$42.70$40.86229,162 shs$848.00 million06/20/2025$42.97$42.34-1.47%$43.27$41.87400,018 shs$862.47 million06/19/2025$42.97$42.97$44.99$42.61254,896 shs$875.26 million06/18/2025$43.46$42.97-1.13%$44.99$42.61254,896 shs$875.30 million06/17/2025$43.81$43.46-0.80%$44.26$41.64210,648 shs$885.24 million06/16/2025$44.30$43.81-1.11%$44.76$43.03147,463 shs$892.37 million06/13/2025$45.03$44.30-1.62%$45.80$43.66178,016 shs$902.35 million06/12/2025$44.60$45.03+0.96%$46.06$43.44269,809 shs$917.22 million06/11/2025$45.85$44.60-2.73%$46.93$44.56232,393 shs$908.46 million06/10/2025$44.51$45.85+3.01%$46.09$43.49298,268 shs$933.92 million06/09/2025$44.56$44.51-0.11%$45.45$43.44207,497 shs$906.62 million Related Companies Avidity Biosciences Stock Chart Ultragenyx Pharmaceutical Stock Chart Protagonist Therapeutics Stock Chart Ascentage Pharma Group International Stock Chart Scholar Rock Stock Chart MoonLake Immunotherapeutics Stock Chart Metsera Stock Chart Viking Therapeutics Stock Chart Kymera Therapeutics Stock Chart MorphoSys Stock Chart Receive PRAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Praxis Precision Medicines and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:PRAX) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredInstant Cash (in 4 clicks)Since 1973, Wall Street has quietly used a strange little pricing quirk to cash flow billions. Now, for the...Awesomely, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Praxis Precision Medicines, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Praxis Precision Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
